Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

JHT: Carl Zeiss Meditec, CenterVue (now iCare), Heidelberg Engineering, Optos, Novartis, Okko.

LG: None.

JJ: None.

DJT: Apellis.

FGH: Acucela, Allergan, Apellis, Bayer, Boehringer-Ingelheim, Bioeq/Formycon, CenterVue (now iCare), Ellex, Roche/Genentech, Geuder, Graybug, Gyroscope, Heidelberg Engineering, IvericBio, Kanghong, LinBioscience, NightStarX, Novartis, Optos, Oxurion Pixium Vision, Oxurion, Stealth BioTherapeutics, Zeiss.

DPC: Apellis, Santen, Allergan/Abbvie, Janssen, Thea.

RPF: Bayer, Novartis, Roche/Genentech, Alimera, Böhringer-Ingelheim, Santhera, Ellex, Novartis, Zeiss, Heidelberg Engineering, CenterVue (now iCare), Biogen.

All outside the submitted work.